✦ LIBER ✦

The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis

✍ Scribed by Yip, S-F; So, C-C; Chan, Ay-Y; Liu, Hs-Y; Wan, Ts-K; Chan, L-C

Book ID: 110056716
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 51 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P124 The prevalence of JAK2 V617F mutati

P124 The prevalence of JAK2 V617F mutation in myelodysplastic syndrome

✍ M. Radič Antolic; R. Zadro; P. Rončevič; S. Bašič Kinda; B. Labar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

reductase enzyme mutation, 5Gdel1G of gen PAI-1) and hyperhomocysteinaemia up to 24 mcmol/L were also discovered. Patient received interferon-alpha, hydroxyurea, acetylsalicylic acid, sulodexide, vitamin therapy B6, B12 with positive effect. We observed disappearance of ascites, reduction of the siz

Recurrent chromosomal aberration at 12q1

Recurrent chromosomal aberration at 12q15 in chronic idiopathic myelofibrosis with or without JAK2V617F mutation

✍ Ohyashiki, K; Tauchi, T; Kuroda, M; Kodama, A; Ohyashiki, J H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

The JAK2 V617F mutation occurs frequentl

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

✍ Kremer, M; Horn, T; Dechow, T; Tzankov, A; Quintanilla-Martínez, L; Fend, F 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

The JAK2 V617F tyrosine kinase mutation

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

✍ Ohyashiki, K; Aota, Y; Akahane, D; Gotoh, A; Miyazawa, K; Kimura, Y; Ohyashiki, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

The JAK2V617F tyrosine kinase mutation i

The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

✍ Ayalew Tefferi; Terra L. Lasho; Susan M. Schwager; David P. Steensma; Ruben A. M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Absence of the JAK2 V617F mutation in pa

Absence of the JAK2 V617F mutation in patients with arterial thrombosis without overt myeloproliferative disease

✍ J. H. SMALBERG; M. P. M. DE MAAT; F. W. G. LEEBEEK 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB